Ho Chi Minh City University of Medicine and Pharmacy   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Ho Chi Minh City Vietnam (1947)

Organization Overview

First Clinical Trial
2004
NCT00670761
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Bui Pham Minh Man | Children's Hospital Number 1, Ho Chi Minh City, Vietnam | Children's Hospital Number 2, Ho Chi Minh City, Vietnam | Department of Obstetrics and Gynecology, University of Medicine and Pharmacy HCMC, Ho Chi Minh City, Vietnam | Ho Chi Minh City University of Medicine and Pharmacy | Ho Chi Minh University of Medicine and Pharmacy | Tudu hospital | Tu Du Hospital | Tu Du Hospital, Ho Chi Minh City | Tu Du Hospital, Ho Chi Minh City, Vietnam | University medical center HCMC | University Medical Center Ho Chi Minh City | University Medical Center Ho Chi Minh City (UMC) | University of Medicine and Pharmacy at HCMC | University of Medicine and Pharmacy at Ho Chi Minh City | University of Medicine and Pharmacy, Ho Chi Minh City | University of Medicine and Pharmacy of Ho Chi Minh City

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Biliary Atresia (Phase 2)

Chronic Periodontitis (Phase 4)

Diarrhea (Phase 4)

Dysentery (Phase 4)

Dysentery, Bacillary (Phase 4)

Endometritis (Phase 4)

Fibrosis (Phase 2)

Foot-and-Mouth Disease (Phase 2)

Hand, Foot and Mouth Disease (Phase 2)

Infertility (Phase 3)

Liver Cirrhosis (Phase 2)

Liver Cirrhosis, Biliary (Phase 2)

Mouth Diseases (Phase 2)

Periodontitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 17
  • # of Trial APIs: 25